Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Preventive effects of Escherichia coli strain Nissle 1917 on acute and chronic intestinal inflammation in two different murine models of colitis.

Schultz M, Strauch UG, Linde HJ, Watzl S, Obermeier F, Göttl C, Dunger N, Grunwald N, Schölmerich J, Rath HC.

Clin Diagn Lab Immunol. 2004 Mar;11(2):372-8.

2.

[Escherichia coli Nissle 1917 as safe vehicles for intestinal immune targeted therapy--a review].

Xia P, Zhu J, Zhu G.

Wei Sheng Wu Xue Bao. 2013 Jun 4;53(6):538-44. Review. Chinese.

PMID:
24028055
3.

[The role of Escherichia coli strain Nissle 1917 in the gastro-intestinal diseases].

Różańska D, Regulska-Ilow B, Choroszy-Król I, Ilow R.

Postepy Hig Med Dosw (Online). 2014 Nov 6;68:1251-6. doi: 10.5604/17322693.1127882. Review. Polish.

4.

Escherichia coli Nissle 1917 in Ulcerative Colitis Treatment: Systematic Review and Meta-analysis.

Losurdo G, Iannone A, Contaldo A, Ierardi E, Di Leo A, Principi M.

J Gastrointestin Liver Dis. 2015 Dec;24(4):499-505. doi: 10.15403/jgld.2014.1121.244.ecn. Review.

5.

Role and mechanisms of action of Escherichia coli Nissle 1917 in the maintenance of remission in ulcerative colitis patients: An update.

Scaldaferri F, Gerardi V, Mangiola F, Lopetuso LR, Pizzoferrato M, Petito V, Papa A, Stojanovic J, Poscia A, Cammarota G, Gasbarrini A.

World J Gastroenterol. 2016 Jun 28;22(24):5505-11. doi: 10.3748/wjg.v22.i24.5505. Review.

6.

Genetic engineering of probiotic Escherichia coli Nissle 1917 for clinical application.

Ou B, Yang Y, Tham WL, Chen L, Guo J, Zhu G.

Appl Microbiol Biotechnol. 2016 Oct;100(20):8693-9. doi: 10.1007/s00253-016-7829-5. Epub 2016 Sep 17. Review.

PMID:
27640192

Supplemental Content

Support Center